Novel biomarkers in major depression
暂无分享,去创建一个
[1] Eva Meisenzahl,et al. Structural MRI correlates for vulnerability and resilience to major depressive disorder. , 2011, Journal of psychiatry & neuroscience : JPN.
[2] Gregor Hasler,et al. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study. , 2011, The American journal of psychiatry.
[3] Wang Xiang,et al. Elevated amygdala activity to negative faces in young adults with early onset major depressive disorder , 2012, Psychiatry Research: Neuroimaging.
[4] Hans-Jürgen Möller,et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. , 2007, Archives of general psychiatry.
[5] A. Schene,et al. Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. , 2012, The Journal of clinical psychiatry.
[6] Allan L Reiss,et al. Aberrant brain activation during a working memory task in psychotic major depression. , 2011, The American journal of psychiatry.
[7] Sergi G. Costafreda,et al. Predictive neural biomarkers of clinical response in depression: A meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies , 2013, Neurobiology of Disease.
[8] Alan J. Thomas,et al. White matter changes in late-life depression: a diffusion tensor imaging study. , 2011, Journal of affective disorders.
[9] G. Dichter,et al. Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards , 2011, Psychiatry Research: Neuroimaging.
[10] L. Fañanás,et al. Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression , 2011, Psychopharmacology.
[11] R. Kahn,et al. Region and state specific glutamate downregulation in major depressive disorder: A meta-analysis of 1H-MRS findings , 2012, Neuroscience & Biobehavioral Reviews.
[12] S. Beach,et al. The relationship of deiodinase 1 genotype and thyroid function to lifetime history of major depression in three independent populations , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[13] J. Diego-Adeliño,et al. Ventromedial prefrontal spectroscopic abnormalities over the course of depression: a comparison among first episode, remitted recurrent and chronic patients. , 2011, Journal of psychiatric research.
[14] N. Wray,et al. Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned , 2010, Molecular Psychiatry.
[15] K. Lesch,et al. Integrating neurobiological markers of depression. , 2010, Archives of general psychiatry.
[16] G. MacQueen,et al. Abnormal hippocampal activation in patients with extensive history of major depression: an fMRI study. , 2012, Journal of psychiatry & neuroscience : JPN.
[17] Fei Wang,et al. Whiter matter abnormalities in medication-naive subjects with a single short-duration episode of major depressive disorder , 2011, Psychiatry Research: Neuroimaging.
[18] Florian Schubert,et al. Abnormal Cingulate and Prefrontal Cortical Neurochemistry in Major Depression After Electroconvulsive Therapy , 2011, Biological Psychiatry.
[19] Peng Xie,et al. Plasma metabonomics as a novel diagnostic approach for major depressive disorder. , 2012, Journal of proteome research.
[20] J. Hauser,et al. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder. , 2011, Journal of affective disorders.
[21] M. Mallar Chakravarty,et al. Longitudinal MR study of brain structure and hippocampus volume in major depressive disorder , 2011, Acta psychiatrica Scandinavica.
[22] Felipe Fregni,et al. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. , 2008, The international journal of neuropsychopharmacology.
[23] R. Duman,et al. Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.
[24] C. Simonsen,et al. Longitudinal MRI study of cortical thickness, perfusion, and metabolite levels in major depressive disorder , 2011, Acta psychiatrica Scandinavica.
[25] K. Coburn,et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[26] J. Neumaier,et al. Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder , 2011, Psychopharmacology.
[27] B. Franke,et al. Serum brain-derived neurotrophic factor: Determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[28] Keith Matthews,et al. Prediction of illness severity in patients with major depression using structural MR brain scans , 2012, Journal of magnetic resonance imaging : JMRI.
[29] Joaquim Radua,et al. Depression is associated with increased sensitivity to signals of disgust: a functional magnetic resonance imaging study. , 2010, Journal of psychiatric research.
[30] Peter McGuffin,et al. Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. , 2011, Journal of affective disorders.
[31] Guillén Fernández,et al. Amygdala responsivity related to memory of emotionally neutral stimuli constitutes a trait factor for depression , 2011, NeuroImage.
[32] Y. Okamoto,et al. DNA Methylation Profiles of the Brain-Derived Neurotrophic Factor (BDNF) Gene as a Potent Diagnostic Biomarker in Major Depression , 2011, PloS one.
[33] Xiang Wang,et al. Evidence of a Dissociation Pattern in Resting-State Default Mode Network Connectivity in First-Episode, Treatment-Naive Major Depression Patients , 2012, Biological Psychiatry.
[34] A. Caspi,et al. Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results. , 2011, Journal of affective disorders.
[35] J. Kowalski,et al. Association Between C-281A and Val66met Functional Polymorphisms of BDNF Gene and Risk of Recurrent Major Depressive Disorder in Polish Population , 2011, Journal of Molecular Neuroscience.
[36] B. Penninx,et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatment , 2010, Molecular Psychiatry.
[37] J. P. Hamilton,et al. Investigating neural primacy in Major Depressive Disorder: Multivariate granger causality analysis of resting-state fMRI time-series data , 2010, Molecular Psychiatry.
[38] P. Terpstra,et al. Poor replication of candidate genes for major depressive disorder using genome-wide association data , 2011, Molecular Psychiatry.
[39] O. Forlenza,et al. Circulating Glial-derived neurotrophic factor is reduced in late-life depression. , 2012, Journal of psychiatric research.
[40] O. Kitis,et al. Smaller Hippocampus Volume Is Associated with Short Variant of 5-HTTLPR Polymorphism in Medication-Free Major Depressive Disorder Patients , 2010, Neuropsychobiology.
[41] Peter T Fox,et al. Abnormal resting state corticolimbic blood flow in depressed unmedicated patients with major depression: A 15O‐H2O PET study , 2012, Human brain mapping.
[42] J. Gorman,et al. PROINFLAMMATORY AND “RESILIENCY” PROTEINS IN THE CSF OF PATIENTS WITH MAJOR DEPRESSION , 2012, Depression and anxiety.
[43] Alan J. Thomas,et al. Regional cerebral blood flow in late-life depression: arterial spin labelling magnetic resonance study , 2012, British Journal of Psychiatry.
[44] H. Baba,et al. Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression. , 2011, Journal of affective disorders.
[45] D. Prvulovic,et al. Biomarkers for major depression and its delineation from neurodegenerative disorders , 2011, Progress in Neurobiology.
[46] Y. S. Zhu,et al. The G-712A polymorphism of brain-derived neurotrophic factor is associated with major depression but not schizophrenia , 2011, Neuroscience Letters.
[47] H. Baba,et al. DURATION OF LAST DEPRESSIVE EPISODE MAY INFLUENCE SERUM BDNF LEVELS IN REMITTED PATIENTS WITH MAJOR DEPRESSION , 2012, Depression and anxiety.
[48] A. Toga,et al. No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression , 2011, Genes, brain, and behavior.
[49] S. Cichon,et al. Evidence for a Relationship Between Genetic Variants at the Brain-Derived Neurotrophic Factor (BDNF) Locus and Major Depression , 2005, Biological Psychiatry.
[50] M. Falagas,et al. Under‐diagnosis of common chronic diseases: prevalence and impact on human health , 2007, International journal of clinical practice.
[51] Y. Lecrubier,et al. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder , 2011, International clinical psychopharmacology.
[52] D. DeMets,et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.
[53] V. Šerić,et al. Serum Brain-derived neurotrophic factor (BDNF): the severity and symptomatic dimensions of depression. , 2011, Psychiatria Danubina.
[54] A. Simmons,et al. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. , 2011, Archives of general psychiatry.
[55] D. Hu,et al. Identifying major depression using whole-brain functional connectivity: a multivariate pattern analysis. , 2012, Brain : a journal of neurology.